Quick Takeaways
- BNTX - BioNTech SE has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$5,527,960.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 13 Insiders of BioNTech SE
- Symbol
- BNTX on Nasdaq
- Location
- Mainz, Germany
What Changed
- Buy value: ; sell value: $5,527,960.
- Net share flow: -50,000.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$5,527,960.
Buys
$0
Shares: 0
Insiders: 0
Sells
$5,527,960
Shares: 50,000
Insiders: 1
Net
-$5,527,960
Shares: -50,000
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 50,000 | $0 | $5,527,960 | -$5,527,960 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
BioNTech SE executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sierk Poetting | Chief Operating Officer | $44,155,907 | -$5,527,960 | -11% | Filing P/S | 22 Apr 2026 |
| Ulrich Wandschneider | Director | Mixed | 18 Mar 2026 | |||
| Ozlem Tureci | Chief Medical Officer | Mixed | 18 Mar 2026 | |||
| Helmut Wolfgang Jeggle | Director | Mixed | 18 Mar 2026 | |||
| Michael Motschmann | Director | Mixed | 18 Mar 2026 | |||
| Kylie Jimenez | Chief People Officer | Mixed | 18 Mar 2026 | |||
| James Timothy Patrick Ryan | Chief Legal Officer and Chief Business Officer; Exhibit List - Exhibit 24 - Power of Attorney | Mixed | 18 Mar 2026 | |||
| Gomez Ramon Zapata | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Ugur Sahin | Chief Executive Officer, 10%+ Owner | Mixed | 18 Mar 2026 | |||
| Rudolf Staudigl | Director | Mixed | 18 Mar 2026 | |||
| Anja Morawietz | Director | Mixed | 18 Mar 2026 | |||
| Annemarie Hanekamp | Chief Commercial Officer | Mixed | 18 Mar 2026 | |||
| Nicola Claire Blackwood | Director | Mixed | 18 Mar 2026 |
Top shareholders of BioNTech SE (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medine GmbH |
13D/G
|
Prof. Ugur Sahin, M.D. |
18%
|
42,178,034
|
$4,386,515,536 | $0 | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.5%
|
5,933,594
|
$564,878,131 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.9%
|
4,484,599
|
$426,934,000 | — | 31 Dec 2025 | |
| Se Flossbach von Storch |
13F
|
Individual |
1.8%
|
4,196,048
|
$399,463,770 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.6%
|
3,800,011
|
$361,761,047 | — | 31 Dec 2025 | |
| DODGE & COX |
13F
|
Company |
1.5%
|
3,614,491
|
$344,099,543 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.66%
|
1,578,094
|
$150,234,549 | — | 31 Dec 2025 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.63%
|
1,506,027
|
$143,373,770 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.57%
|
1,361,221
|
$129,588,239 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.52%
|
1,244,867
|
$118,511,339 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.48%
|
1,152,884
|
$109,754,540 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.47%
|
1,134,941
|
$108,046,383 | — | 31 Dec 2025 | |
| GSK plc |
13F
|
Company |
0.37%
|
889,824
|
$84,711,245 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.31%
|
736,597
|
$70,124,035 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
680,669
|
$64,799,832 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
678,175
|
$64,562,260 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.25%
|
604,916
|
$57,590,455 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.24%
|
577,900
|
$55,015,819 | — | 31 Dec 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.21%
|
507,655
|
$48,328,756 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.2%
|
488,552
|
$46,510,150 | — | 31 Dec 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.2%
|
481,397
|
$46,397,000 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
470,000
|
$44,744,000 | — | 31 Dec 2025 | |
| Sierk Poetting |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
540,901
|
$44,155,907 | -$5,527,960 | 22 Apr 2026 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
446,283
|
$42,486,142 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
437,565
|
$41,656,188 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
400,593
|
$38,136,454 | — | 31 Dec 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.17%
|
400,382
|
$38,093,046 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.16%
|
388,867
|
$37,020,138 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.16%
|
375,000
|
$35,700,000 | — | 31 Dec 2025 | |
| Davern Capital Partners, LP |
13F
|
Company |
0.15%
|
371,216
|
$35,339,763 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.15%
|
368,923
|
$35,121,470 | — | 31 Dec 2025 | |
| LBP AM SA |
13F
|
Company |
0.15%
|
368,584
|
$35,089,197 | — | 31 Dec 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.15%
|
365,333
|
$34,780,000 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.13%
|
321,111
|
$30,636,396 | — | 31 Dec 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.12%
|
281,830
|
$26,830,216 | — | 31 Dec 2025 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.11%
|
273,073
|
$25,996,550 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
272,365
|
$25,929,148 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.11%
|
260,107
|
$24,765,961 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
256,225
|
$24,392,621 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.1%
|
250,331
|
$23,831,511 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
249,045
|
$23,709,084 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
241,573
|
$22,997,750 | — | 31 Dec 2025 | |
| CenterBook Partners LP |
13F
|
Company |
0.1%
|
236,175
|
$22,483,860 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
0.09%
|
221,529
|
$21,090,000 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.08%
|
197,500
|
$18,802,000 | — | 31 Dec 2025 | |
| Asset Managment Groupama |
13F
|
Individual |
0.08%
|
189,069
|
$17,999,369 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
173,089
|
$16,478,074 | — | 31 Dec 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
169,178
|
$16,110,725 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.07%
|
160,464
|
$15,276,173 | — | 31 Dec 2025 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.06%
|
152,339
|
$14,382,572 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for BioNTech SE
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Sierk Poetting | BNTX | Ordinary Shares | Sale | -11.1% | $5,527,960 | $110.56 | -50,000 | 399,387 | 22 Apr 2026 | See Footnote |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.